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AQUAPORIN-4–POSITIVE MYELITIS
ASSOCIATED WITH SJÖGREN SYNDROME AND
COLONIC ADENOCARCINOMA
Neuromyelitis optica (NMO) is an inflammatory dis-
order of the CNS with prominent involvement of the
optic nerve and the spinal cord. An autoantibody
against aquaporin-4 (AQP4), a water channel abun-
dant on astrocytic foot processes, is the biomarker
of the disease.1
The term neuromyelitis optica spectrum disorders
(NMOSD) includes AQP4-IgG-positive syndromes
that may only partially fulfill contemporary criteria
for diagnosis of NMO.2
NMOSD are frequently associated with other
autoimmune disorders and there are increasing re-
ports of NMOSD in patients with cancer.3,4
Case report. We report a case of an 80-year-old
nonsmoking Caucasian woman with a diagnosis of
primary Sjögren syndrome 1.5 years prior to
presentation (seropositive for SSA [Ro60 and Ro52
. 100 U/mL]; SSB-negative) confirmed by salivary
gland biopsy and a positive Schirmer test. The
diagnosis was established during workup for a
sensory neuropathy; peroneal nerve biopsy showed
involvement of both myelin and axons with
perivascular T-lymphocytic infiltration (figure). She
was treated with rituximab with an excellent clinical
improvement.
The patient presented to the emergency depart-
ment with sudden loss of strength in her left lower
limb. The cerebral CT scan showed chronic micro-
vascular leukoencephalopathy and she was admitted
for suspicion of anterior cerebral artery stroke. The
next day, symmetric paraparesis and bilateral hyperre-
flexia developed, with a T4 sensory level and loss of
voluntary sphincter control. The spinal MRI showed
a longitudinally extensive transverse myelitis with dif-
fuse inhomogeneous gadolinium enhancement (fig-
ure). The CSF showed pleocytosis with monocytic
predominance (387 cells/mm3), no atypical cells,
slightly low glucose (40% of the serum), and elevated
protein (2,989 mg/L) without any oligoclonal bands.
CSF culture and viral PCR (herpes simplex virus
1 and 2) were negative. The cerebral MRI showed
chronic vascular leukoencephalopathy lesions. Serol-
ogies for Lyme disease, syphilis, HIV, and tuberculo-
sis were negative. Detected non-organ-specific
autoantibodies were SSA (Ro 52 . 240 U/mL and
Ro 60 . 108 U/mL; normal , 5 U/mL). Neural
autoantibodies were not detected (specifically acetyl-
choline receptor muscle and ganglionic type, voltage-
gated calcium channel P/Q-type and N-type,
GAD65, voltage-gated potassium channel, alpha-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
receptor, g-aminobutyric acid B receptor, NMDA
receptor, collapsin response-mediator protein 5,
amphiphysin, anti-neuronal nuclear antibody 1 and
2, Purkinje cell cytoplasmic antibody type 1, and
Ma1/Ma2) except for AQP4-IgG that was positive
at 1:1,000 serum dilution by cell-binding assay (com-
mercially available, M23 isoform). A serum specimen
collected a year earlier that was retrospectively tested
was also positive for AQP4-IgG at a lower dilution
(1:500).
The patient was treated with high-dose methyl-
prednisolone followed by oral tapering with predni-
sone. Plasma exchange was initiated because the
patient developed tetraplegia; the patient’s motor
skills in lower extremities subsequently improved
rapidly.
Due to the patient’s age and history of diverticu-
litis in the previous year, total-body CT was per-
formed in search of a tumor and revealed a
perforated sigmoid mass.
The patient underwent exploratory laparotomy
and left hemicolectomy. Histopathology confirmed
a locally invasive colonic adenocarcinoma
(pT4aN1aG2L1) without evidence of systemic
metastasis. The patient died 2 days later from
hemorrhagic shock. The family denied permission
for autopsy.
Discussion. This is a case of an elderly woman
presenting with AQP4-IgG-seropositive transverse
myelitis in the context of primary Sjögren syndrome
with sensory neuropathy and colonic adenocarcinoma.
In a cohort of 2,743 AQP4-IgG-seropositive pa-
tients with NMOSD, only 12.1% were older than
65 years.5 However, the clinical presentation with
longitudinally extensive transverse myelitis at
disease onset, AQP4-IgG seropositivity, and severe
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neurologic impairment is similar to presentations re-
ported in elderly women.5
AQP4 autoimmunity is strongly associated with
Sjögren syndrome, representing the coexistence of 2
different disorders rather than NMOSD as a symp-
tom of the systemic autoimmune disorder.3
This patient was positive for AQP4-IgG a year
prior to the presentation of transverse myelitis,
without any signs of an NMO-type clinical presen-
tation. The existence of AQP4-IgG before NMO
onset has been described in 4 patients with coexist-
ing myasthenia gravis; higher AQP4-IgG levels were
noticed at NMO clinical presentation, as in this
patient.6
Cancer coexistence with NMOSD was 5% in
large cohorts but up to 15% in cohorts with older pa-
tients. Breast, thymus, lung, nasopharynx, cervix,
bladder, gastrointestinal tract, thyroid, pituitary
gland, ovary, prostate, skin neoplasms, carcinoid tu-
mors, and hematologic cancers are reported.4,7
AQP4 is not expressed in colonic tissue, but to our
knowledge colonic adenocarcinomas have not been
studied for AQP4 expression at the RNA or the pro-
tein level. As this patient’s tumor was not tested for
AQP4 expression, we can only speculate that the pres-
ence of AQP4-IgG a year prior to disease onset could
be a marker of the underlying oncologic disease. A
simple coexistence of the cancer and the NMOSD is
also possible.
From the Division of Neurology (T.R., A.Z., S.R.), Pourtalès Hos-
pital, Neuchatel, Switzerland; and Department of Clinical Neuro-
sciences (F.O.), University Hospital of Lausanne, Switzerland.
Author contributions: Thomas Rossel: concept and design of the
paper, acquisition of data, analysis and interpretation, and drafting
of the manuscript. Anastasia Zekeridou: concept and design of the
paper, analysis and interpretation of the data, drafting of the
manuscript, and critical revision for important intellectual content.
François Ochsner: acquisition of data, analysis and interpretation,
and critical revision for important intellectual content. Susanne
Renaud: acquisition of data, analysis and interpretation, and critical
revision of the draft for important intellectual content.
Acknowledgment: The authors thank Prof. Vanda Lennon, MD,
PhD, Mayo Clinic, Rochester, MN, for revising the manuscript.
Study funding: No targeted funding reported.
Disclosure: The authors report no disclosures. Go to Neurology.org/nn
for full disclosure forms.
Figure Nerve biopsy findings and spinal MRI
(A–C) Superficial peroneal nerve biopsy (hematoxylin & eosin stain). (A) Fibrous nerve fascicle without myelin reflecting
myelino-axonal involvement (green circle) associated with slight vasculitic infiltrate (red circle) without arteriole lesion (blue
circle). (B, C) Predominance of T-lymphocyte infiltration (CD3 staining, B) in comparison to B lymphocytes (CD20 staining, C).
(D–F) Spinal MRI with predominantly central longitudinally transverse myelitis from C1 to T10 (T2-weighted image, D) with
heterogeneous gadolinium enhancement (T1-weighted images, E and F).
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